FGF23 and hyperphosphatemia: In rats with 5/6 Nx, there was also no hyperphosphatemia, but secondary hyperparathyroidism and elevated FGF23 levels were observed compared with sham rats; however, treatment with PF-06869206 did not reduce PTH or FGF23 levels.